Reduced Tyk2/SHP-1 interaction and lack of SHP-1 mutation in a kindred of familial hemophagocytic lymphohistiocytosis

Leukemia

Volumn 12, Issue 2, 1998, Pages 200-206

  Tabrizi, M ^a   Yang, W ^a   Jiao, H ^a   DeVries, E M C ^b   Platanias, L C ^c   Arico, M ^d   Yi, T ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

FHLH; SHP 1; Signal transduction; Tyk2; Tyrosine phosphorylation

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILY STUDY; FEMALE; GENE MUTATION; HEMOPHAGOCYTIC SYNDROME; HISTIOCYTOSIS; HUMAN; HUMAN CELL; MALE; MOLECULAR CLONING; MONONUCLEAR CELL; PRIORITY JOURNAL;

EID: 0031933076     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400949     Document Type: Article

References (48)

1. Janka GE. Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 1983; 140: 221-230.
2. Farquhar JW, Claireaux AF. Familial hemophagocytic reticulosis. Arch Dis Child 1952; 27: 519-525.
3. Nelson P, Santamaria A, Olson RL, Nayak NC. Generalized lymphohistiocytic infiltration. A familial disease not previously described and different from Letterer-Siwe disease and Chediak-Higashi syndrome. Pediatrics 1961; 27: 931-950.
4. MacMahon HE, Bedizel M, Ellis CA. Familial erythrophagocytic lymphohistiocytosis. Pediatrics 1963; 32: 868-879.
5. Mozziconacci P, Nezelof C, Attal C et al. La lymphohitiocytose familiale. Arch Fr Pediatr 1965; 22: 385-408.
6. Peterson RA, Kuwabara T. Ocular manifestation of familial lymphohistiocytosis. Arch Ophthalmol 1968; 79: 413-418.
7. Frisell E, Bjorksten B, Holmgren C, Angstrom T. Familial occurrence of histiocytosis. Clin Genet 1977; 11: 163-170.
8. Arico M, Janka G, Fischer A et al. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia 1996; 10: 197-203.
9. Shultz LD, Schweitzer PA, Rajan TV et al. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 1993; 73: 1445-1454.
10. Tsui HW, Siminovitch KA, de Souza L, Tsui FW. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nat Genet 1993; 4: 124-129.
11. Adachi M, Fishcher EH, Ihle J et al. Mammalian SH2-containing protein tyrosine phosphatases. Cell 1996; 85: 15.
12. Yi T, Cleveland JL, Ihle JN. Identification of novel protein tyrosine phosphatases of hematopoietic cells by polymerase chain reaction amplification. Blood 1991; 78: 2222-2228.
13. Yi TL, Cleveland JL, Ihle JN. Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13. Mol Cell Biol 1992; 12: 836-846.
14. Shen SH, Bastien L, Posner BI, Chretien P. A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases (unpublished erratum appears in Nature 1991; 353: 868). Nature 1991; 352: 736-739.
15. Plutzky J, Neel BG, Rosenberg RD. Isolation of a src homology 2-containing tyrosine phosphatase. Proc Natl Acad Sci USA 1992; 89: 1123-1127.
16. Matthews RJ, Bowne DB, Flores E, Thomas ML. Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences. Mol Cell Biol 1992; 12: 2396-2405.
17. Songyang Z, Cantley LC. Recognition and specificity in protein tyrosine kinase-mediated signalling. TIBS 1995; 20: 470-475.
18. Burshtyn DN, Yang W, Yi T, Long EO. A novel phosphotyrosine motif with a critical amino acid at position -2 for the SH2 domain-mediated activation of the tyrosine phosphatase SHP-1 (in process citation). J Biol Chem 1997; 272: 13066-13072.
19. Pei D, Neel BG, Walsh CT. Overexpression, purification, and characterization of SHPTP1, a Src homology 2-containing protein-tyrosine-phosphatase. Proc Natl Acad Sci USA 1993; 90: 1092-1096.
20. Pei D, Lorenz U, Klingmuller U, Neel BG, Walsh CT. Intramolecular regulation of protein tyrosine phosphatase SH-PTP1 : a new function for Src homology 2 domains. Biochemistry 1994; 33: 15483-15493.
21. Yi T, Mui AL, Krystal G, Ihle JN. Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor beta chain and clown-regulates IL-3-induced tyrosine phosphorylation and mitogenesis. Mol Cell Biol 1993; 13: 7577-7586.
22. Yi T, Ihle JN. Association of hematopoietic cell phosphatase with c-Kit after stimulation with c-Kit ligand Mol Cell Biol 1993; 13: 3350-3358.
23. Yi T, Zhang J, Miura O, Ihle JN. Hematopoietic cell phosphatase associates with erythropoietin (Epo) receptor after Epo-induced receptor tyrosine phosphorylation: identification of potential binding sites. Blood 1995; 85: 87-95.
24. David M, Chen HE, Goelz S, Larner AC, Neel BG. Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 1995; 15: 7050-7058.
25. Klingmuller U, Lorenz U, Cantley LC, Neel BG, Lodish HF. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 1995; 80: 729-738.
26. D'Ambrosio D, Hippen KL, Minskoff SA et al. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1 (see comments). Science 1995; 268: 293-297.
27. Doody CM, Justement LB, Delibrias CC et al. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 1995; 269: 242-244.
28. Cyster JG, Goodnow CC. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 1995; 2: 13-24.
29. Pani G, Kozlowski M, Cambier JC, Mills GB, Siminovitch KA. Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling. J Exp Med 1995; 181: 2077-2084.
30. Burshtyn DM, Scharenberg AM, Wagtmann N et al. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 1996; 4: 77-85.
31. Van Zant G, Shultz LD. Hematopoietic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev). Exp Hematol 1989; 17: 81-87.
32. Chen H, Chang S, Trub T, Neel BG. Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 1996; 16: 3685-3697.
33. Tapley P, Shevde NK, Schweitzer PA et al. Increased G-CSF response of bone marrow cells from hematopoietic cell phosphatase deficient viable motheaten mice. Exp Hematol 1996; 25: 122-131.
34. Jiao H, Yang W, Berrada K, Tibrizi M, Shultz L, Yi T. Macrophages from motheaten and viable motheaten mutant mice show increased proliferative response to GM-CSF: detection of potential HCP substrates in GM-CSF signal transduction. Exp Hematol 1997; 25: 592-600.
35. Ihle JN. Cytokine receptor signalling. Nature 1995; 377: 591-594.
36. Jiao H, Berrada K, Yang W, Tabrizi M, Platanias LC, Yi T. Direct association and dephosphorylation of Jak2 kinase by SH2 domain-containing protein tyrosine phosphatase SHP-1. Mol Cell Biol 1996; 16: 6985-6992.
37. Ihle JN. STATs: signal transducers and activators of transcription. Cell 1996; 84: 331-334.
38. Roussel MF, Cleveland JL, Shurtleff SA, Sherr CJ. Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling. Nature 1991; 353: 361-363.
39. Sanger F, Nichklen S, Coulson A. DNA-sequencing with chain-termination inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-5467.
40. Yang W, Tabrizi M, Berrada K, Yi T, SHP-1 C-terminus interacts with novel substrates in IL-3 and Epo mitogenic responses. Mol Cell Biol 1997 (submitted).
41. Yetter A, Uddin S, Krolewski JJ, Jiao H, Yi T, Platanias LC. Association of the interferon-dependent tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase. J Biol Chem 1995; 270: 18179-18182.
42. Yi T, Gilbert DJ, Jenkins NA, Copeland NG, Ihle JN. Assignment of a novel protein tyrosine phosphatase gene (Hcph) to mouse chromosome 6. Genomics 1992; 14: 793-795.
43. Macchi P, Villa A, Gillani S et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 1995; 377: 65-68.
44. Russell SM, Tayebi N, Nakajima H et al. Mutation of Jak3 in a patient with SCID: essential rule of Jak3 in lymphoid development. Science 1995; 270: 797-800.
45. Binari R, Perrimon N. Stripe-specific regulation of pair-rule genes by hopscotch, a putative Jak family tyrosine kinase in Drosophila. Genes Dev 1994; 8: 300-312.
46. Luo H, Hanratty WP, Dearolf CR. An amino acid substitution in the Drosophila hopTum-1 Jak kinase causes leukemia-like hematopoietic defects. EMBO J 1995; 14: 1412-1420.
47. Harrison DA, Binari R, Nahreini TS, Gilman M, Perrimon N. Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects. EMBO J 1995; 14: 2857-2865.
48. Luo H, Rose P, Barber D et al. Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways. Mol Cell Biol 1997; 17: 1562-1571.